Buy Stocks Easy | About Us
December 4, 2020
Buy Stocks Easy | Online Stocks

RETA


Buy Reata Pharmaceuticals, Inc. Stock (symbol: RETA) Easy Online

Company Name: Reata Pharmaceuticals, Inc.

Symbol: RETA

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2016

RETA Current Share Price

Today's RETA ( Reata Pharmaceuticals, Inc. ) opening price: $

Yesterday's RETA ( Reata Pharmaceuticals, Inc. ) closing price: $

Reata Pharmaceuticals, Inc. Stock ( symbol: RETA ) Price Chart since IPO (2016):

12 Months Reata Pharmaceuticals, Inc. Stock ( symbol: RETA ) Price Chart

Popular Questions about Reata Pharmaceuticals, Inc. Public Stock ( RETA )

A: Reata Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is RETA

A: Reata Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2016

A: Reata Pharmaceuticals, Inc.'s stock (RETA symbol) price at ther IPO (initial Public Offering) was $

Q: Is RETA stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Reata Pharmaceuticals, Inc. stock (symbol: RETA) at the beginning of 2019, at the opening share price of $79.7700, with a minimum of $200, by now your shares would be worth $700 and your profit would be $500 - SHOW ONLY IF PROFIT.

Buy Reata Pharmaceuticals, Inc. Stock Easy Online

Reata Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Reata Pharmaceuticals, Inc. Stock Price Yesterday



 


Reata Pharmaceuticals, Inc. Stock Price – Last Week




 


Reata Pharmaceuticals, Inc. Stock Price – Last Month




 


Reata Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://www.fool.com/investing/2019/11/26/reata-pharmaceuticals-just-raised-505-million-to-t.aspx
                            

                                
Reata Pharmaceuticals Just Raised $505 Million to Treat Orphan Diseases: What it Means for Investors

                                
                                
The capital sets the biotech up nicely to launch two successful drugs.


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/18/1948866/0/en/Reata-Pharmaceuticals-Inc-Announces-Closing-of-Class-A-Common-Stock-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
                            

                                
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

                                
                                
PLANO, Texas, Nov.  18, 2019  (GLOBE NEWSWIRE) -- Reata Pharmaceuti...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/14/1946807/0/en/Reata-Pharmaceuticals-Inc-Announces-Pricing-of-Upsized-Class-A-Common-Stock-Public-Offering.html
                            

                                
Reata Pharmaceuticals, Inc. Announces Pricing of Upsized Class A Common Stock Public Offering

                                
                                
PLANO, Texas, Nov.  13, 2019  (GLOBE NEWSWIRE) -- Reata Pharmaceuti...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4306006-reata-pharmaceuticals-reta-ceo-warren-huff-discusses-positive-topline-pivotal-year-1-cardinal
                            

                                
Reata Pharmaceuticals (RETA) CEO Warren Huff Discusses Positive Topline Pivotal Year 1 CARDINAL Data (Transcript)

                                
                                
Reata Pharmaceuticals (RETA) CEO Warren Huff Discusses Positive Top...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305967-reata-pharmaceuticals-confusion-secondary-endpoint
                            

                                
Reata Pharmaceuticals: Confusion On The Secondary Endpoint

                                
                                
Reata Pharmaceuticals: Confusion On The Secondary Endpoint


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/615675/reata-pharmaceuticals-inc-reta-reports-q3-loss-tops-revenue-estimates
                            

                                
Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue s...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/12/why-shares-of-reata-pharmaceuticals-rocketed-more.aspx
                            

                                
Why Shares of Reata Pharmaceuticals Rocketed More Than 150% in October

                                
                                
A drug trial showed promise in treating a particularly stubborn dis...


                            

                        
                    

                


                            

                    


                        
                            https://www.investors.com/news/technology/reata-stock-tumbles-despite-positive-results-kidney-disease-test/
                            

                                
This Biotech Has Rocketed 181% Since October — Did It Just Tap Out?

                                
                                
Shares of Reata Pharmaceuticals were briefly halted late Monday jus...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/reata-pharma-kidney-drug-meets-study-goals-stock-halted-2019-11-11
                            

                                
Reata Pharma kidney drug meets study goals, stock halted

                                
                                
Reata Pharmaceuticals Inc. shares were halted in the extended sessi...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.